Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Aarti Pharmalabs Limited Call Transcript 2025

Aug 5, 2025

59697_rns_2025-08-05_8ba8fb59-2fec-4dd1-a808-fc167de59cbf.pdf

Call Transcript

Open in viewer

Opens in your device viewer

==> picture [137 x 53] intentionally omitted <==

August 05, 2025

To, Listing/ Compliance Department BSE LTD. Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai - 400 001

SCRIP CODE: 543748

To, Listing/ Compliance Department National Stock Exchange of India Limited “Exchange Plaza”, Plot No. C/1, G Block, Bandra Kurla Complex, Bandra (E), Mumbai – 400 051 SYMBOL: AARTIPHARM

Dear Sir/Madam,

Sub: Intimation of Earnings Conference Call Ref: Regulation 30 of the SEBI (LODR) Regulations 2015

This is to inform you that the Earnings Conference Call for Investors and Analysts, which would be a Group meet, has been scheduled on Wednesday, August 13, 2025 at 4:00 P.M. (IST) to discuss the Company's Q1-FY26 Financial Results .

Please find attached herewith Invitation for the same.

Kindly take the same on your record.

Thanking you,

Yours faithfully, For AARTI PHARMALABS LIMITED

Jeevan Digitally signed by Jeevan Bhargav Bhargav Mondkar Date: 2025.08.05 Mondkar 17:32:06 +05'30' JEEVAN MONDKAR COMPANY SECRETARY AND LEGAL HEAD ICSI M. NO. A22565

Encl. a/a.

==> picture [452 x 59] intentionally omitted <==

CONFERENCE CALL

August 01, 2025

==> picture [16 x 97] intentionally omitted <==

AARTI PHARMALABS

Hosted by Nuvama Wealth Management

India Equity Research

==> picture [80 x 31] intentionally omitted <==

==> picture [109 x 32] intentionally omitted <==

w Nuvama Wealth Management is hosting a conference call with the management of Aarti Pharmalabs to discuss the Company’s Q1FY26 financial results on Wednesday, August 13, 2025 at 4.00 PM IST. Management will be represented by:

Mr. Rashesh Gogri – Chairman.

Mrs. Hetal Gogri Gala – Vice Chairperson & Managing Director.

Mr. Piyush Lakhani – Chief Financial Officer.

Details of the conference call are as under:

Time:4.00 PM IST on Wednesday, August 13, 2025 Time:4.00 PM IST on Wednesday, August 13, 2025 Time:4.00 PM IST on Wednesday, August 13, 2025
Conference dial-in:
India: Mumbai
: Primary access number+ 91 22 6280 1123
+91 22 7115 8024
USA : +1 866 7462 133
UK : +0 808 1011 573
Singapo re Toll Free No.: +800 1012 045
Hong K ong Toll Free No.: +800 9644 48
Call lea derMr. Shrikant Ako lkar
urther in formation, please contact:

For further information, please contact:

Shrikant Akolkar

Nuvama Wealth Management Ltd. E-mail: [email protected]

Express Join with DiamondPass™

Nuvama Wealth Management Ltd.

Nuvama Research is also available on research.nuvama.com, Bloomberg – NUVA, Thomson Reuters and Factset